Malcolm J. Moore, MD
Princess Margaret Hospital, Canada
9
2
9
N/A
0
11
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+6 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Stephane Culine, MD
Institut du Cancer de Montpellier - Val d'Aurelle
Shared therapeutic areas:
Worked with same sponsors:
David C. Smith, MD
University of Michigan Rogel Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Joaquim Bellmunt, MD, PhD
Vall d'Hebron University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Michael Leahy, MBChB, FRACP, FRCP, FRC Path
Fremantle Hospital
Shared therapeutic areas:
Worked with same sponsors:
Christoph Zielinski, MD
Allgemeines Krankenhaus - Universitatskliniken
Shared therapeutic areas:
Worked with same sponsors:
Jose Baselga, MD
Vall d'Hebron University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Andreas Boehle, MD
Universitaetsklinikum Schleswig-Holstein - Campus Luebeck
Shared therapeutic areas:
Worked with same sponsors:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
John P. Neoptolemos, MD
Royal Liverpool University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Henry C. Pitot, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Perifosine in Treating Patients With Advanced Pancreatic Cancer
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
All 9 trials loaded